# Heart Failure Mortality Prediction Model Summary

## Executive Summary

This model predicts the likelihood of death (DEATH_EVENT) in patients with heart failure using clinical and demographic features. It demonstrates good discriminatory ability with an AUC of 0.86 and solid overall accuracy of 81.7%. The upstream data quality is generally reasonable, though there are warnings due to outliers in several lab measurements and about 10% of cases flagged as anomalous, which may affect model reliability.

## Performance

- **AUC:** 0.859
- **Accuracy:** 0.817
- **F1 score (positive class):** 0.667

The model shows strong ability to distinguish between patients who survive and those who do not, as indicated by the AUC near 0.86. An accuracy above 81% suggests it correctly classifies most cases overall. The F1 score of 0.67 reflects a balanced performance on identifying death events, though there is room for improvement in sensitivity or precision for the positive class.

## Feature Importance

Feature importance is based on SHAP values, which quantify each feature's contribution to the model's predictions. The most influential feature is 'time', where longer follow-up times relate strongly to the outcome. Lower 'ejection_fraction' values increase risk, indicating poorer heart function raises mortality risk. Elevated 'serum_creatinine' levels, a marker of kidney function, also increase risk. Older 'age' and presence of 'diabetes' further raise mortality likelihood. Other features like 'sex', 'creatinine_phosphokinase', 'serum_sodium', 'smoking', and 'platelets' have smaller but meaningful impacts on risk assessment.

## Data Quality Considerations

The data quality status is WARN due to the presence of outliers in multiple numeric columns including creatinine_phosphokinase, ejection_fraction, platelets, serum_creatinine, and serum_sodium. Additionally, about 10% of patient records were flagged as anomalous by an IsolationForest detector, suggesting unusual profiles or potential data entry issues. While there are no missing values or duplicates, these anomalies and outliers could affect model stability and generalizability if not addressed.

## Recommendations

It is recommended to further investigate and potentially mitigate the impact of outliers, for example by winsorizing extreme values or applying transformations. Reviewing the anomalous 10% of rows to confirm whether they represent valid rare cases or errors is important; these could be excluded or modeled separately if appropriate. Clinicians and data scientists should be cautious when applying the model to populations with characteristics similar to the flagged anomalies. Continuous monitoring of model performance and data quality is advised to maintain trustworthiness in clinical use.
